Skip to main content
Top
Published in: European Radiology 12/2020

Open Access 01-12-2020 | Prostate Cancer | Urogenital

Comparison of machine learning algorithms to predict clinically significant prostate cancer of the peripheral zone with multiparametric MRI using clinical assessment categories and radiomic features

Authors: Simon Bernatz, Jörg Ackermann, Philipp Mandel, Benjamin Kaltenbach, Yauheniya Zhdanovich, Patrick N. Harter, Claudia Döring, Renate Hammerstingl, Boris Bodelle, Kevin Smith, Andreas Bucher, Moritz Albrecht, Nicolas Rosbach, Lajos Basten, Ibrahim Yel, Mike Wenzel, Katrin Bankov, Ina Koch, Felix K.-H. Chun, Jens Köllermann, Peter J. Wild, Thomas J. Vogl

Published in: European Radiology | Issue 12/2020

Login to get access

Abstract

Objectives

To analyze the performance of radiological assessment categories and quantitative computational analysis of apparent diffusion coefficient (ADC) maps using variant machine learning algorithms to differentiate clinically significant versus insignificant prostate cancer (PCa).

Methods

Retrospectively, 73 patients were included in the study. The patients (mean age, 66.3 ± 7.6 years) were examined with multiparametric MRI (mpMRI) prior to radical prostatectomy (n = 33) or targeted biopsy (n = 40). The index lesion was annotated in MRI ADC and the equivalent histologic slides according to the highest Gleason Grade Group (GrG). Volumes of interest (VOIs) were determined for each lesion and normal-appearing peripheral zone. VOIs were processed by radiomic analysis. For the classification of lesions according to their clinical significance (GrG ≥ 3), principal component (PC) analysis, univariate analysis (UA) with consecutive support vector machines, neural networks, and random forest analysis were performed.

Results

PC analysis discriminated between benign and malignant prostate tissue. PC evaluation yielded no stratification of PCa lesions according to their clinical significance, but UA revealed differences in clinical assessment categories and radiomic features. We trained three classification models with fifteen feature subsets. We identified a subset of shape features which improved the diagnostic accuracy of the clinical assessment categories (maximum increase in diagnostic accuracy ΔAUC = + 0.05, p < 0.001) while also identifying combinations of features and models which reduced overall accuracy.

Conclusions

The impact of radiomic features to differentiate PCa lesions according to their clinical significance remains controversial. It depends on feature selection and the employed machine learning algorithms. It can result in improvement or reduction of diagnostic performance.

Key Points

• Quantitative imaging features differ between normal and malignant tissue of the peripheral zone in prostate cancer.
• Radiomic feature analysis of clinical routine multiparametric MRI has the potential to improve the stratification of clinically significant versus insignificant prostate cancer lesions in the peripheral zone.
• Certain combinations of standard multiparametric MRI reporting and assessment categories with feature subsets and machine learning algorithms reduced the diagnostic performance over standard clinical assessment categories alone.
Appendix
Available only for authorised users
Literature
2.
go back to reference Ferlay J, Soerjomataram I, Dikshit R et al (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–E386CrossRef Ferlay J, Soerjomataram I, Dikshit R et al (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–E386CrossRef
3.
go back to reference Sun Y, Reynolds HM, Parameswaran B et al (2019) Multiparametric MRI and radiomics in prostate cancer: a review. Australas Phys Eng Sci Med 42:3–25CrossRef Sun Y, Reynolds HM, Parameswaran B et al (2019) Multiparametric MRI and radiomics in prostate cancer: a review. Australas Phys Eng Sci Med 42:3–25CrossRef
4.
go back to reference Moore CM, Robertson NL, Arsanious N et al (2013) Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review. Eur Urol 63:125–140CrossRef Moore CM, Robertson NL, Arsanious N et al (2013) Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review. Eur Urol 63:125–140CrossRef
5.
go back to reference Siddiqui MM, Rais-Bahrami S, Turkbey B et al (2015) Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer. JAMA 313:390–397CrossRef Siddiqui MM, Rais-Bahrami S, Turkbey B et al (2015) Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer. JAMA 313:390–397CrossRef
6.
go back to reference Kristiansen G (2012) Diagnostic and prognostic molecular biomarkers for prostate cancer. Histopathology 60:125–141CrossRef Kristiansen G (2012) Diagnostic and prognostic molecular biomarkers for prostate cancer. Histopathology 60:125–141CrossRef
8.
go back to reference Stewart GD, Van Neste L, Delvenne P et al (2013) Clinical utility of an epigenetic assay to detect occult prostate cancer in histopathologically negative biopsies: results of the MATLOC study. J Urol 189:1110–1116CrossRef Stewart GD, Van Neste L, Delvenne P et al (2013) Clinical utility of an epigenetic assay to detect occult prostate cancer in histopathologically negative biopsies: results of the MATLOC study. J Urol 189:1110–1116CrossRef
9.
go back to reference Lambin P, Rios-Velazquez E, Leijenaar R et al (2012) Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer 48:441–446CrossRef Lambin P, Rios-Velazquez E, Leijenaar R et al (2012) Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer 48:441–446CrossRef
10.
go back to reference Wirth M, Berges R, Fröhner M, et al (2012) Interdisziplinäre Leitlinie der Qualität S3 zur Früherkennung, Diagnose und Therapie der verschiedenen Stadien des Prostatakarzinoms. Leitlinienprogr Onkol der Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften eV (AWMF), Dtsch Krebsgesellschaft eV und Dtsch Krebshilfe (DKH) Version 5. https://doi.org/10.1055/s-0032-1313080 Wirth M, Berges R, Fröhner M, et al (2012) Interdisziplinäre Leitlinie der Qualität S3 zur Früherkennung, Diagnose und Therapie der verschiedenen Stadien des Prostatakarzinoms. Leitlinienprogr Onkol der Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften eV (AWMF), Dtsch Krebsgesellschaft eV und Dtsch Krebshilfe (DKH) Version 5. https://​doi.​org/​10.​1055/​s-0032-1313080
11.
go back to reference Matoso A, Epstein JI (2019) Defining clinically significant prostate cancer on the basis of pathological findings. Histopathology 74:135–145CrossRef Matoso A, Epstein JI (2019) Defining clinically significant prostate cancer on the basis of pathological findings. Histopathology 74:135–145CrossRef
12.
go back to reference Epstein JI, Egevad L, Amin MB et al (2016) The 2014 international society of urological pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma definition of grading patterns and proposal for a new grading system. Am J Surg Pathol 40:244–252 Epstein JI, Egevad L, Amin MB et al (2016) The 2014 international society of urological pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma definition of grading patterns and proposal for a new grading system. Am J Surg Pathol 40:244–252
13.
go back to reference Evans AJ (2018) Treatment effects in prostate cancer. Mod Pathol 31:110–121CrossRef Evans AJ (2018) Treatment effects in prostate cancer. Mod Pathol 31:110–121CrossRef
14.
go back to reference Schröder FH, Hugosson J, Roobol MJ et al (2014) Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up. Lancet 384:2027–2035CrossRef Schröder FH, Hugosson J, Roobol MJ et al (2014) Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up. Lancet 384:2027–2035CrossRef
15.
go back to reference Barentsz JO, Weinreb JC, Verma S et al (2016) Synopsis of the PI-RADS v2 guidelines for multiparametric prostate magnetic resonance imaging and recommendations for use. Eur Urol 69:41–49CrossRef Barentsz JO, Weinreb JC, Verma S et al (2016) Synopsis of the PI-RADS v2 guidelines for multiparametric prostate magnetic resonance imaging and recommendations for use. Eur Urol 69:41–49CrossRef
16.
go back to reference Muller BG, Shih JH, Sankineni S et al (2015) Prostate cancer: interobserver agreement and accuracy with the revised prostate imaging reporting and data system at multiparametric MR imaging. Radiology 277:741–750CrossRef Muller BG, Shih JH, Sankineni S et al (2015) Prostate cancer: interobserver agreement and accuracy with the revised prostate imaging reporting and data system at multiparametric MR imaging. Radiology 277:741–750CrossRef
17.
go back to reference Gillies RJ, Kinahan PE, Hricak H (2016) Radiomics: images are more than pictures, they are data. Radiology 278:563–577CrossRef Gillies RJ, Kinahan PE, Hricak H (2016) Radiomics: images are more than pictures, they are data. Radiology 278:563–577CrossRef
20.
go back to reference Park JE, Park SY, Kim HJ, Kim HS (2019) Reproducibility and generalizability in radiomics modeling: possible strategies in radiologic and statistical perspectives. Korean J Radiol 20:1124–1137CrossRef Park JE, Park SY, Kim HJ, Kim HS (2019) Reproducibility and generalizability in radiomics modeling: possible strategies in radiologic and statistical perspectives. Korean J Radiol 20:1124–1137CrossRef
21.
go back to reference Bonekamp D, Kohl S, Wiesenfarth M et al (2018) Radiomic machine learning for characterization of prostate lesions with MRI: comparison to ADC values. Radiology 289:128–137CrossRef Bonekamp D, Kohl S, Wiesenfarth M et al (2018) Radiomic machine learning for characterization of prostate lesions with MRI: comparison to ADC values. Radiology 289:128–137CrossRef
22.
go back to reference Nketiah G, Elschot M, Kim E et al (2017) T2-weighted MRI-derived textural features reflect prostate cancer aggressiveness: preliminary results. Eur Radiol 27:3050–3059CrossRef Nketiah G, Elschot M, Kim E et al (2017) T2-weighted MRI-derived textural features reflect prostate cancer aggressiveness: preliminary results. Eur Radiol 27:3050–3059CrossRef
25.
go back to reference Yuan Y, Qin W, Buyyounouski M et al (2019) Prostate cancer classification with multiparametric MRI transfer learning model. Med Phys 46:756–765CrossRef Yuan Y, Qin W, Buyyounouski M et al (2019) Prostate cancer classification with multiparametric MRI transfer learning model. Med Phys 46:756–765CrossRef
27.
go back to reference Kumar V, Gu Y, Basu S et al (2012) Radiomics: the process and the challenges. Magn Reson Imaging 30:1234–1248CrossRef Kumar V, Gu Y, Basu S et al (2012) Radiomics: the process and the challenges. Magn Reson Imaging 30:1234–1248CrossRef
28.
go back to reference Fedorov A, Beichel R, Kalphaty-Cramer J et al (2012) 3D slicers as an image computing platform for the quantitative imaging network. Magn Reson Imaging 30:1323–1341CrossRef Fedorov A, Beichel R, Kalphaty-Cramer J et al (2012) 3D slicers as an image computing platform for the quantitative imaging network. Magn Reson Imaging 30:1323–1341CrossRef
31.
go back to reference Zwanenburg A, Leger S, Vallières M, Löck S (2016) Image biomarker standardisation initiative. arXiv preprint arXiv:1612.07003 Zwanenburg A, Leger S, Vallières M, Löck S (2016) Image biomarker standardisation initiative. arXiv preprint arXiv:1612.07003
33.
go back to reference Traverso A, Wee L, Dekker A, Gillies R (2018) Repeatability and reproducibility of radiomic features: a systematic review. Int J Radiat Oncol Biol Phys 102:1143–1158CrossRef Traverso A, Wee L, Dekker A, Gillies R (2018) Repeatability and reproducibility of radiomic features: a systematic review. Int J Radiat Oncol Biol Phys 102:1143–1158CrossRef
35.
go back to reference Wang J, Wu CJ, Bao ML, Zhang J, Wang XN, Zhang YD (2017) Machine learning-based analysis of MR radiomics can help to improve the diagnostic performance of PI-RADS v2 in clinically relevant prostate cancer. Eur Radiol 27:4082–4090 Wang J, Wu CJ, Bao ML, Zhang J, Wang XN, Zhang YD (2017) Machine learning-based analysis of MR radiomics can help to improve the diagnostic performance of PI-RADS v2 in clinically relevant prostate cancer. Eur Radiol 27:4082–4090
36.
go back to reference Baumann K (2003) Cross-validation as the objective function for variable-selection techniques. TrAC Trends Anal Chem 22:395–406CrossRef Baumann K (2003) Cross-validation as the objective function for variable-selection techniques. TrAC Trends Anal Chem 22:395–406CrossRef
37.
go back to reference Wild PJ, Fuchs T, Stoehr R et al (2009) Detection of urothelial bladder cancer cells in voided urine can be improved by a combination of cytology and standardized microsatellite analysis. Cancer Epidemiol Biomarkers Prev 18:1798–1806CrossRef Wild PJ, Fuchs T, Stoehr R et al (2009) Detection of urothelial bladder cancer cells in voided urine can be improved by a combination of cytology and standardized microsatellite analysis. Cancer Epidemiol Biomarkers Prev 18:1798–1806CrossRef
38.
go back to reference Pedregosa F, Varoquaux G, Gramfort A et al (2011) Scikit-learn: machine learning in python. J Mach Learn Res 12:2825–2830 Pedregosa F, Varoquaux G, Gramfort A et al (2011) Scikit-learn: machine learning in python. J Mach Learn Res 12:2825–2830
39.
go back to reference Al Nemer AM, Elsharkawy T, Elshawarby M et al (2017) The updated grading system of prostate carcinoma: an inter-observer agreement study among general pathologists in an academic practice. APMIS 125:957–961CrossRef Al Nemer AM, Elsharkawy T, Elshawarby M et al (2017) The updated grading system of prostate carcinoma: an inter-observer agreement study among general pathologists in an academic practice. APMIS 125:957–961CrossRef
40.
go back to reference Wibmer A, Hricak H, Gondo T et al (2016) Haralick texture analysis of prostate MRI: utility for differentiating non-cancerous prostate from prostate cancer and differentiating prostate cancers with different Gleason scores. Eur Radiol 25:2840–2850CrossRef Wibmer A, Hricak H, Gondo T et al (2016) Haralick texture analysis of prostate MRI: utility for differentiating non-cancerous prostate from prostate cancer and differentiating prostate cancers with different Gleason scores. Eur Radiol 25:2840–2850CrossRef
41.
go back to reference Stoyanova R, Takhar M, Tschudi Y et al (2017) Prostate cancer radiomics and the promise of radiogenomics. Transl Cancer Res 5:432–447CrossRef Stoyanova R, Takhar M, Tschudi Y et al (2017) Prostate cancer radiomics and the promise of radiogenomics. Transl Cancer Res 5:432–447CrossRef
42.
go back to reference Turkbey B, Shah VP, Pang Y et al (2011) Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images? Radiology 258:488–495CrossRef Turkbey B, Shah VP, Pang Y et al (2011) Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images? Radiology 258:488–495CrossRef
43.
go back to reference Kwak JT, Sankineni S, Xu S et al (2016) Correlation of magnetic resonance imaging with digital histopathology in prostate. Int J Comput Assist Radiol Surg 11:657–666CrossRef Kwak JT, Sankineni S, Xu S et al (2016) Correlation of magnetic resonance imaging with digital histopathology in prostate. Int J Comput Assist Radiol Surg 11:657–666CrossRef
45.
go back to reference Baeßler B, Weiss K, Dos Santos DP (2019) Robustness and reproducibility of radiomics in magnetic resonance imaging: a phantom study. Invest Radiol 54:221–228CrossRef Baeßler B, Weiss K, Dos Santos DP (2019) Robustness and reproducibility of radiomics in magnetic resonance imaging: a phantom study. Invest Radiol 54:221–228CrossRef
Metadata
Title
Comparison of machine learning algorithms to predict clinically significant prostate cancer of the peripheral zone with multiparametric MRI using clinical assessment categories and radiomic features
Authors
Simon Bernatz
Jörg Ackermann
Philipp Mandel
Benjamin Kaltenbach
Yauheniya Zhdanovich
Patrick N. Harter
Claudia Döring
Renate Hammerstingl
Boris Bodelle
Kevin Smith
Andreas Bucher
Moritz Albrecht
Nicolas Rosbach
Lajos Basten
Ibrahim Yel
Mike Wenzel
Katrin Bankov
Ina Koch
Felix K.-H. Chun
Jens Köllermann
Peter J. Wild
Thomas J. Vogl
Publication date
01-12-2020
Publisher
Springer Berlin Heidelberg
Published in
European Radiology / Issue 12/2020
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-020-07064-5

Other articles of this Issue 12/2020

European Radiology 12/2020 Go to the issue